| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 62 |
| 1 | INFLIXIMAB | 54 |
| 2 | RISANKIZUMAB-RZAA | 24 |
| 3 | PREDNISONE | 22 |
| 4 | INTERFERON BETA-1A | 17 |
| 5 | UPADACITINIB | 15 |
| 6 | ACETAMINOPHEN | 14 |
| 7 | USTEKINUMAB | 13 |
| 8 | ERGOCALCIFEROL | 12 |
| 9 | OMEPRAZOLE MAGNESIUM | 12 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | GLYBURIDE AND METFORMIN HYDROCHLORIDE | 1 | 0.0046 |
| 1 | INFLIXIMAB-DYYB | 8 | 0.0023 |
| 2 | SMOFLIPID | 1 | 0.0011 |
| 3 | PANITUMUMAB | 9 | 0.0006 |
| 4 | PRALSETINIB | 1 | 0.0005 |
| 5 | TAPINAROF | 1 | 0.0005 |
| 6 | BRODALUMAB | 1 | 0.0005 |
| 7 | NIRAPARIB | 10 | 0.0005 |
| 8 | ERGOCALCIFEROL | 12 | 0.0004 |
| 9 | PILOCARPINE HYDROCHLORIDE | 1 | 0.0004 |
| # | Drug class | Count |
|---|---|---|
| 0 | Tumor Necrosis Factor Blocker [EPC] | 80 |
| 1 | Interleukin-23 Antagonist [EPC] | 37 |
| 2 | Corticosteroid [EPC] | 33 |
| 3 | Nonsteroidal Anti-inflammatory Drug [EPC] | 27 |
| 4 | Benzodiazepine [EPC] | 20 |
| 5 | Interferon beta [EPC] | 17 |
| 6 | Janus Kinase Inhibitor [EPC] | 15 |
| 7 | Interleukin-12 Antagonist [EPC] | 13 |
| 8 | Proton Pump Inhibitor [EPC] | 13 |
| 9 | Epidermal Growth Factor Receptor Antagonist [EPC] | 12 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Aryl Hydrocarbon Receptor Agonist [EPC] | 1 | 0.0005 |
| 1 | Interleukin-17 Receptor A Antagonist [EPC] | 1 | 0.0005 |
| 2 | Provitamin D2 Compound [EPC] | 12 | 0.0004 |
| 3 | Lipid Emulsion [EPC] | 1 | 0.0004 |
| 4 | GLP-2 Analog [EPC] | 5 | 0.0004 |
| 5 | Interleukin-23 Antagonist [EPC] | 37 | 0.0004 |
| 6 | Calcitonin Gene-related Peptide Receptor Antagonist [EPC] | 2 | 0.0003 |
| 7 | Epidermal Growth Factor Receptor Antagonist [EPC] | 12 | 0.0003 |
| 8 | Neonatal Fc Receptor Blocker [EPC] | 1 | 0.0002 |
| 9 | Non-Standardized Insect Allergenic Extract [EPC] | 1 | 0.0002 |